Form 6-K CHINA UNICOM (HONG KONG) For: Nov 25

�

�

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

�

�

FORM 6-K

�

�

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the Month of November 2014

Commission File Number 1-15028

�

�

China Unicom (Hong Kong) Limited

(Exact Name of Registrant as Specified in Its Charter)

�

�

75/F, The Center,

99 Queen�s Road Central, Hong Kong

(Address of principal executive offices)

�

�

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form�20-F or Form�40-F.)

Form 20-F��x������������Form 40-F���

(Indicate by check mark if the registrant is submitting the Form�6-K on paper as permitted by Regulation�S-T Rule�101(b)(1):���.)

(Indicate by check mark if the registrant is submitting the Form�6-K on paper as permitted by Regulation�S-T Rule�101(b)(7):���.)

(Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule�12g3-2(b) under the Securities Exchange Act of 1934.)

Yes���������������No��x

(If �Yes� is marked, indicate below the file number assigned to the registrant in connection with Rule�12g3-2(b):82-������������.)

�

�

�

---

EXHIBITS

�

Exhibit Number	��	�
1	��	Announcement dated November 24, 2014 in respect of Issue of Promissory Note.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

�

	�	CHINA UNICOM (HONG KONG) LIMITED
	�		�	����������������(Registrant)
Date: November 25, 2014	�		�		�
	�		�	By:	�	/s/ Chang Xiaobing
	�		�	Name:	�	Chang Xiaobing
	�		�	Title:	�	Chairman and Chief Executive Officer

---

Exhibit 1

Hong Kong Exchange and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

�

�

(incorporated in Hong Kong with limited liability)

(Stock Code: 0762)

ISSUE OF PROMISSORY NOTE

China United Network Communications Corporation Limited (�CUCL�), a wholly-owned subsidiary of China Unicom (Hong Kong) Limited (the �Company�), will launch the issue of the third tranche of promissory note for the year 2014 of an amount of RMB5 billion on 27�November 2014. CUCL has published a public announcement in relation to the issue of the promissory note.

CUCL, a wholly-owned subsidiary of the Company, has published a public announcement in relation to CUCL�s issue of the third tranche of promissory note for the year 2014 of an amount of RMB5 billion. The documents relating to the issue of the promissory note have been published on the websites of Shanghai Clearing House and Chinamoney.com.cn at http://www.shclearing.com and http://www.chinamoney.com.cn, respectively.

CUCL will launch the issue of the third tranche of promissory note for the year 2014 on 27�November 2014. The issue will be completed on 28�November 2014. The final coupon rate will be announced separately upon completion of the issue.

By Order of the Board of

China Unicom (Hong Kong) Limited

Chu Ka Yee

Company Secretary

Hong Kong, 24�November 2014

As at the date of this announcement, the Board of Directors of the Company comprises:

�

Executive Directors:	��	Chang Xiaobing, Lu Yimin, Li Fushen and Zhang Junan
Non-executive Director:	��	Cesareo Alierta Izuel
Independent�Non-executive�Directors:	��	Cheung Wing Lam Linus, Wong Wai Ming, John Lawson Thornton, Chung Shui Ming Timpson, Cai Hongbin and Law Fan Chiu Fun Fanny

�

1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Coca-Cola Europacific Partners plc Announces Q1 Trading Update & Interim Dividend Declaration
• Hemogenyx Pharmaceuticals PLC Announces Final Results
• Argo 2023 Annual Financial Report